Literature DB >> 23027186

Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.

Weixia Liu1, Lijuan Li, Yi Sun, Wei Chen, Zhe Wan, Ruoyu Li, Wei Liu.   

Abstract

Aspergillus biofilms were prepared from 22 strains of Aspergillus spp. via a 96-well plate-based method. Using a broth microdilution checkerboard technique with the XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] colorimetric assay, we demonstrated a synergistic antifungal activity against 18 of 22 Aspergillus biofilm strains with a combination of caspofungin and amphotericin B and against 13 of 22 strains with a combination of caspofungin and voriconazole. We did not observe antagonism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027186      PMCID: PMC3497162          DOI: 10.1128/AAC.00687-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Combination therapy with caspofungin and amphotericin B lipid complex.

Authors:  Linda R Lum; Thomas F Turco; John Leone
Journal:  Am J Health Syst Pharm       Date:  2002-01-01       Impact factor: 2.637

2.  Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.

Authors:  Cidália Pina-Vaz; Acácio Gonçalves Rodrigues; Sofia Costa-de-Oliveira; Elisabete Ricardo; Per-Anders Mårdh
Journal:  J Antimicrob Chemother       Date:  2005-08-22       Impact factor: 5.790

Review 3.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

4.  In vivo biofilm composition of Aspergillus fumigatus.

Authors:  Céline Loussert; Christine Schmitt; Marie-Christine Prevost; Viviane Balloy; Elie Fadel; Bruno Philippe; Catherine Kauffmann-Lacroix; Jean Paul Latgé; Anne Beauvais
Journal:  Cell Microbiol       Date:  2009-11-04       Impact factor: 3.715

5.  In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors:  Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

6.  An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus.

Authors:  Anne Beauvais; Christine Schmidt; Stéphanie Guadagnini; Pascal Roux; Emmanuelle Perret; Christine Henry; Sophie Paris; Adeline Mallet; Marie-Christine Prévost; Jean Paul Latgé
Journal:  Cell Microbiol       Date:  2007-02-16       Impact factor: 3.715

7.  Characteristics of biofilm formation by Candida albicans.

Authors:  G Ramage; K Vandewalle; B L Wickes; J L López-Ribot
Journal:  Rev Iberoam Micol       Date:  2001-12       Impact factor: 1.044

8.  Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus.

Authors:  Eilidh Mowat; John Butcher; Sue Lang; Craig Williams; Gordon Ramage
Journal:  J Med Microbiol       Date:  2007-09       Impact factor: 2.472

9.  Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.

Authors:  Eilidh Mowat; Sue Lang; Craig Williams; Elaine McCulloch; Brian Jones; Gordon Ramage
Journal:  J Antimicrob Chemother       Date:  2008-09-26       Impact factor: 5.790

10.  Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.

Authors:  Wei Liu; Michail S Lionakis; Russell E Lewis; Nathan Wiederhold; Gregory S May; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

View more
  8 in total

Review 1.  Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.

Authors:  Marion Aruanno; Emmanouil Glampedakis; Frédéric Lamoth
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.

Authors:  Yong Liao; Suteng Yang; Lin Cong; Xuelian Lu; Junhong Ao; Rongya Yang
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

3.  In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm.

Authors:  Rong Zeng; Min Li; Qing Chen; Le Wang; Ping Zhan; Chong Wang; Guixia Lv; Yongnian Shen; Weida Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 4.  The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence.

Authors:  Vito Valiante; Juliane Macheleidt; Martin Föge; Axel A Brakhage
Journal:  Front Microbiol       Date:  2015-04-16       Impact factor: 5.640

Review 5.  Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.

Authors:  Jill Adler-Moore; Russell E Lewis; Roger J M Brüggemann; Bart J A Rijnders; Andreas H Groll; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

Review 6.  Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.

Authors:  Tristan Born; Marion Aruanno; Eleftheria Kampouri; Matteo Mombelli; Pierre Monney; Piergiorgio Tozzi; Frederic Lamoth
Journal:  Mycopathologia       Date:  2022-03-10       Impact factor: 3.785

7.  Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Scedosporium and Fusarium spp.

Authors:  Katerina Vikelouda; Maria Simitsopoulou; Lemonia Skoura; Charalampos Antachopoulos; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

Review 8.  Application of caspofungin in China compared with amphotericin B and fluconazole.

Authors:  Chunyu Zhang; Jiaoying Cheng; Yan Jiang; Junyang Liu
Journal:  Ther Clin Risk Manag       Date:  2014-09-10       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.